ILA Ann: Island receives FDA feedback on Phase 2a clinical study - 20th Jan 2023, 9:51am

annb0t

annb0t

Top 20
ILA Ann: Island receives FDA feedback on Phase 2a clinical study
Price Sensitive: Y
Date: 20th Jan 2023, 9:51am

>>> Read announcement: Google: ILA Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
ILA Ann: Island Annual General Meeting online link for shareholders - 31st Oct 2023, 10:03am
Replies
0
Views
68
annb0t
annb0t
annb0t
ILA Ann: Island Pharmaceuticals granted key U.S. patent for ISLA-101 - 13th Sep 2023, 9:06am
Replies
0
Views
63
annb0t
annb0t
annb0t
ILA Ann: Island receives FDA go-ahead for ISLA-101 program - 16th May 2023, 9:09am
Replies
0
Views
100
annb0t
annb0t
annb0t
ILA Ann: Island submits responses to FDA questions for ISLA-101 - 17th Apr 2023, 9:32am
Replies
0
Views
133
annb0t
annb0t
annb0t
ILA Ann: Island online investor briefing presentation - 15th Dec 2022, 9:18am
Replies
0
Views
136
annb0t
annb0t
Top Bottom